nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—CYP1A2—Anastrozole—breast cancer	0.136	0.401	CbGbCtD
Triamterene—CYP1A2—Toremifene—breast cancer	0.124	0.367	CbGbCtD
Triamterene—CYP1A2—Tamoxifen—breast cancer	0.0454	0.134	CbGbCtD
Triamterene—CYP1A2—Fluorouracil—breast cancer	0.0334	0.0987	CbGbCtD
Triamterene—SCNN1B—mammary gland—breast cancer	0.0149	0.0701	CbGeAlD
Triamterene—SCNN1G—nipple—breast cancer	0.0146	0.0686	CbGeAlD
Triamterene—SCNN1A—mammary gland—breast cancer	0.0138	0.0647	CbGeAlD
Triamterene—SCNN1B—nipple—breast cancer	0.0123	0.0579	CbGeAlD
Triamterene—SCNN1D—epithelium—breast cancer	0.00984	0.0462	CbGeAlD
Triamterene—SCNN1G—endometrium—breast cancer	0.00882	0.0414	CbGeAlD
Triamterene—SCNN1B—epithelium—breast cancer	0.00831	0.039	CbGeAlD
Triamterene—SCNN1G—pituitary gland—breast cancer	0.00798	0.0375	CbGeAlD
Triamterene—SCNN1A—epithelium—breast cancer	0.00768	0.036	CbGeAlD
Triamterene—SCNN1B—endometrium—breast cancer	0.00745	0.035	CbGeAlD
Triamterene—Lamotrigine—SCN10A—breast cancer	0.00737	0.82	CrCbGaD
Triamterene—SCNN1D—female reproductive system—breast cancer	0.00731	0.0343	CbGeAlD
Triamterene—SCNN1G—female reproductive system—breast cancer	0.00731	0.0343	CbGeAlD
Triamterene—SCNN1D—adrenal gland—breast cancer	0.00713	0.0335	CbGeAlD
Triamterene—SCNN1B—adipose tissue—breast cancer	0.00672	0.0315	CbGeAlD
Triamterene—SCNN1A—uterus—breast cancer	0.00634	0.0298	CbGeAlD
Triamterene—SCNN1A—pituitary gland—breast cancer	0.00623	0.0293	CbGeAlD
Triamterene—SCNN1A—adipose tissue—breast cancer	0.00621	0.0291	CbGeAlD
Triamterene—SCNN1D—endocrine gland—breast cancer	0.00618	0.029	CbGeAlD
Triamterene—SCNN1B—female reproductive system—breast cancer	0.00617	0.029	CbGeAlD
Triamterene—SCNN1B—adrenal gland—breast cancer	0.00602	0.0283	CbGeAlD
Triamterene—SCNN1A—female reproductive system—breast cancer	0.0057	0.0268	CbGeAlD
Triamterene—SCNN1A—adrenal gland—breast cancer	0.00557	0.0261	CbGeAlD
Triamterene—SCNN1B—endocrine gland—breast cancer	0.00522	0.0245	CbGeAlD
Triamterene—SCNN1A—female gonad—breast cancer	0.00519	0.0244	CbGeAlD
Triamterene—SCNN1A—endocrine gland—breast cancer	0.00483	0.0227	CbGeAlD
Triamterene—SCNN1D—lymph node—breast cancer	0.00427	0.0201	CbGeAlD
Triamterene—SCNN1B—lymph node—breast cancer	0.00361	0.017	CbGeAlD
Triamterene—SCNN1A—lymph node—breast cancer	0.00334	0.0157	CbGeAlD
Triamterene—CYP1A2—nipple—breast cancer	0.00274	0.0129	CbGeAlD
Triamterene—Lamotrigine—ABCB1—breast cancer	0.00162	0.18	CrCbGaD
Triamterene—CYP1A2—endocrine gland—breast cancer	0.00116	0.00544	CbGeAlD
Triamterene—Dermatitis—Exemestane—breast cancer	0.000922	0.00328	CcSEcCtD
Triamterene—Headache—Exemestane—breast cancer	0.000917	0.00326	CcSEcCtD
Triamterene—Dizziness—Ixabepilone—breast cancer	0.000913	0.00325	CcSEcCtD
Triamterene—Hypersensitivity—Idarubicin—breast cancer	0.000909	0.00323	CcSEcCtD
Triamterene—Dry mouth—Tamoxifen—breast cancer	0.000908	0.00323	CcSEcCtD
Triamterene—Thrombocytopenia—Vinblastine—breast cancer	0.000897	0.00319	CcSEcCtD
Triamterene—Diarrhoea—Anastrozole—breast cancer	0.00089	0.00316	CcSEcCtD
Triamterene—Diarrhoea—Letrozole—breast cancer	0.00089	0.00316	CcSEcCtD
Triamterene—Vomiting—Ixabepilone—breast cancer	0.000878	0.00312	CcSEcCtD
Triamterene—Anaphylactic shock—Melphalan—breast cancer	0.000871	0.0031	CcSEcCtD
Triamterene—Thrombocytopenia—Tamoxifen—breast cancer	0.000871	0.0031	CcSEcCtD
Triamterene—Rash—Ixabepilone—breast cancer	0.000871	0.0031	CcSEcCtD
Triamterene—Dermatitis—Ixabepilone—breast cancer	0.00087	0.00309	CcSEcCtD
Triamterene—Nausea—Exemestane—breast cancer	0.000869	0.00309	CcSEcCtD
Triamterene—Dry mouth—Goserelin—breast cancer	0.000867	0.00308	CcSEcCtD
Triamterene—Headache—Ixabepilone—breast cancer	0.000865	0.00308	CcSEcCtD
Triamterene—Fatigue—Chlorambucil—breast cancer	0.000862	0.00306	CcSEcCtD
Triamterene—Dizziness—Anastrozole—breast cancer	0.00086	0.00306	CcSEcCtD
Triamterene—Dizziness—Letrozole—breast cancer	0.00086	0.00306	CcSEcCtD
Triamterene—Thrombocytopenia—Melphalan—breast cancer	0.000853	0.00303	CcSEcCtD
Triamterene—Anaphylactic shock—Goserelin—breast cancer	0.00085	0.00302	CcSEcCtD
Triamterene—Diarrhoea—Idarubicin—breast cancer	0.000844	0.003	CcSEcCtD
Triamterene—Diarrhoea—Raloxifene—breast cancer	0.000844	0.003	CcSEcCtD
Triamterene—Thrombocytopenia—Goserelin—breast cancer	0.000832	0.00296	CcSEcCtD
Triamterene—Vomiting—Letrozole—breast cancer	0.000827	0.00294	CcSEcCtD
Triamterene—Vomiting—Anastrozole—breast cancer	0.000827	0.00294	CcSEcCtD
Triamterene—Photosensitivity reaction—Paclitaxel—breast cancer	0.000822	0.00292	CcSEcCtD
Triamterene—Nausea—Ixabepilone—breast cancer	0.00082	0.00292	CcSEcCtD
Triamterene—Rash—Letrozole—breast cancer	0.00082	0.00291	CcSEcCtD
Triamterene—Rash—Anastrozole—breast cancer	0.00082	0.00291	CcSEcCtD
Triamterene—Dermatitis—Letrozole—breast cancer	0.000819	0.00291	CcSEcCtD
Triamterene—Dermatitis—Anastrozole—breast cancer	0.000819	0.00291	CcSEcCtD
Triamterene—Dizziness—Raloxifene—breast cancer	0.000816	0.0029	CcSEcCtD
Triamterene—Headache—Letrozole—breast cancer	0.000815	0.0029	CcSEcCtD
Triamterene—Headache—Anastrozole—breast cancer	0.000815	0.0029	CcSEcCtD
Triamterene—Hyperkalaemia—Epirubicin—breast cancer	0.000806	0.00287	CcSEcCtD
Triamterene—Vomiting—Raloxifene—breast cancer	0.000785	0.00279	CcSEcCtD
Triamterene—Vomiting—Idarubicin—breast cancer	0.000785	0.00279	CcSEcCtD
Triamterene—Rash—Raloxifene—breast cancer	0.000778	0.00277	CcSEcCtD
Triamterene—Rash—Idarubicin—breast cancer	0.000778	0.00277	CcSEcCtD
Triamterene—Hypokalaemia—Capecitabine—breast cancer	0.000778	0.00277	CcSEcCtD
Triamterene—Dermatitis—Idarubicin—breast cancer	0.000777	0.00276	CcSEcCtD
Triamterene—Dermatitis—Raloxifene—breast cancer	0.000777	0.00276	CcSEcCtD
Triamterene—Blood urea increased—Epirubicin—breast cancer	0.000774	0.00275	CcSEcCtD
Triamterene—Headache—Raloxifene—breast cancer	0.000773	0.00275	CcSEcCtD
Triamterene—Headache—Idarubicin—breast cancer	0.000773	0.00275	CcSEcCtD
Triamterene—Nausea—Letrozole—breast cancer	0.000772	0.00275	CcSEcCtD
Triamterene—Nausea—Anastrozole—breast cancer	0.000772	0.00275	CcSEcCtD
Triamterene—Fatigue—Tamoxifen—breast cancer	0.000767	0.00273	CcSEcCtD
Triamterene—Anaphylactic shock—Vinorelbine—breast cancer	0.000761	0.00271	CcSEcCtD
Triamterene—Fatigue—Melphalan—breast cancer	0.000751	0.00267	CcSEcCtD
Triamterene—Hyperkalaemia—Doxorubicin—breast cancer	0.000746	0.00265	CcSEcCtD
Triamterene—Thrombocytopenia—Vinorelbine—breast cancer	0.000745	0.00265	CcSEcCtD
Triamterene—Hypersensitivity—Chlorambucil—breast cancer	0.000736	0.00262	CcSEcCtD
Triamterene—Nausea—Idarubicin—breast cancer	0.000733	0.00261	CcSEcCtD
Triamterene—Nausea—Raloxifene—breast cancer	0.000733	0.00261	CcSEcCtD
Triamterene—Fatigue—Goserelin—breast cancer	0.000733	0.00261	CcSEcCtD
Triamterene—Photosensitivity—Methotrexate—breast cancer	0.000725	0.00258	CcSEcCtD
Triamterene—Asthenia—Chlorambucil—breast cancer	0.000717	0.00255	CcSEcCtD
Triamterene—Blood urea increased—Doxorubicin—breast cancer	0.000717	0.00255	CcSEcCtD
Triamterene—Thrombocytopenia—Thiotepa—breast cancer	0.000712	0.00253	CcSEcCtD
Triamterene—Renal failure acute—Methotrexate—breast cancer	0.000689	0.00245	CcSEcCtD
Triamterene—Diarrhoea—Chlorambucil—breast cancer	0.000684	0.00243	CcSEcCtD
Triamterene—Photosensitivity—Epirubicin—breast cancer	0.000678	0.00241	CcSEcCtD
Triamterene—Hypersensitivity—Vinblastine—breast cancer	0.000675	0.0024	CcSEcCtD
Triamterene—Photosensitivity reaction—Capecitabine—breast cancer	0.000674	0.0024	CcSEcCtD
Triamterene—Jaundice—Docetaxel—breast cancer	0.000663	0.00236	CcSEcCtD
Triamterene—Asthenia—Vinblastine—breast cancer	0.000657	0.00234	CcSEcCtD
Triamterene—Fatigue—Vinorelbine—breast cancer	0.000656	0.00233	CcSEcCtD
Triamterene—Hypersensitivity—Tamoxifen—breast cancer	0.000656	0.00233	CcSEcCtD
Triamterene—Renal failure acute—Epirubicin—breast cancer	0.000645	0.00229	CcSEcCtD
Triamterene—Jaundice—Capecitabine—breast cancer	0.000642	0.00228	CcSEcCtD
Triamterene—Hypersensitivity—Melphalan—breast cancer	0.000642	0.00228	CcSEcCtD
Triamterene—Asthenia—Tamoxifen—breast cancer	0.000638	0.00227	CcSEcCtD
Triamterene—Vomiting—Chlorambucil—breast cancer	0.000635	0.00226	CcSEcCtD
Triamterene—Anaphylactic shock—Mitoxantrone—breast cancer	0.000628	0.00223	CcSEcCtD
Triamterene—Anaphylactic shock—Irinotecan—breast cancer	0.000628	0.00223	CcSEcCtD
Triamterene—Photosensitivity—Doxorubicin—breast cancer	0.000628	0.00223	CcSEcCtD
Triamterene—Fatigue—Thiotepa—breast cancer	0.000627	0.00223	CcSEcCtD
Triamterene—Diarrhoea—Vinblastine—breast cancer	0.000627	0.00223	CcSEcCtD
Triamterene—Hypersensitivity—Goserelin—breast cancer	0.000626	0.00223	CcSEcCtD
Triamterene—Asthenia—Melphalan—breast cancer	0.000625	0.00222	CcSEcCtD
Triamterene—Thrombocytopenia—Irinotecan—breast cancer	0.000615	0.00219	CcSEcCtD
Triamterene—Thrombocytopenia—Mitoxantrone—breast cancer	0.000615	0.00219	CcSEcCtD
Triamterene—Anaphylactic shock—Gemcitabine—breast cancer	0.000611	0.00217	CcSEcCtD
Triamterene—Asthenia—Goserelin—breast cancer	0.00061	0.00217	CcSEcCtD
Triamterene—Diarrhoea—Tamoxifen—breast cancer	0.000609	0.00216	CcSEcCtD
Triamterene—Dizziness—Vinblastine—breast cancer	0.000606	0.00215	CcSEcCtD
Triamterene—Anaphylactic shock—Fluorouracil—breast cancer	0.000601	0.00214	CcSEcCtD
Triamterene—Thrombocytopenia—Gemcitabine—breast cancer	0.000599	0.00213	CcSEcCtD
Triamterene—Renal failure acute—Doxorubicin—breast cancer	0.000597	0.00212	CcSEcCtD
Triamterene—Diarrhoea—Melphalan—breast cancer	0.000596	0.00212	CcSEcCtD
Triamterene—Nausea—Chlorambucil—breast cancer	0.000594	0.00211	CcSEcCtD
Triamterene—Thrombocytopenia—Fluorouracil—breast cancer	0.000589	0.00209	CcSEcCtD
Triamterene—Dizziness—Tamoxifen—breast cancer	0.000588	0.00209	CcSEcCtD
Triamterene—Vomiting—Vinblastine—breast cancer	0.000582	0.00207	CcSEcCtD
Triamterene—Diarrhoea—Goserelin—breast cancer	0.000581	0.00207	CcSEcCtD
Triamterene—Headache—Vinblastine—breast cancer	0.000574	0.00204	CcSEcCtD
Triamterene—Vomiting—Tamoxifen—breast cancer	0.000566	0.00201	CcSEcCtD
Triamterene—Dizziness—Goserelin—breast cancer	0.000562	0.002	CcSEcCtD
Triamterene—Rash—Tamoxifen—breast cancer	0.000561	0.00199	CcSEcCtD
Triamterene—Hypersensitivity—Vinorelbine—breast cancer	0.000561	0.00199	CcSEcCtD
Triamterene—Dermatitis—Tamoxifen—breast cancer	0.00056	0.00199	CcSEcCtD
Triamterene—Headache—Tamoxifen—breast cancer	0.000557	0.00198	CcSEcCtD
Triamterene—Vomiting—Melphalan—breast cancer	0.000554	0.00197	CcSEcCtD
Triamterene—Rash—Melphalan—breast cancer	0.000549	0.00195	CcSEcCtD
Triamterene—Dermatitis—Melphalan—breast cancer	0.000549	0.00195	CcSEcCtD
Triamterene—Asthenia—Vinorelbine—breast cancer	0.000546	0.00194	CcSEcCtD
Triamterene—Nausea—Vinblastine—breast cancer	0.000544	0.00193	CcSEcCtD
Triamterene—Hypokalaemia—Epirubicin—breast cancer	0.000542	0.00193	CcSEcCtD
Triamterene—Fatigue—Irinotecan—breast cancer	0.000541	0.00192	CcSEcCtD
Triamterene—Fatigue—Mitoxantrone—breast cancer	0.000541	0.00192	CcSEcCtD
Triamterene—Vomiting—Goserelin—breast cancer	0.00054	0.00192	CcSEcCtD
Triamterene—Rash—Goserelin—breast cancer	0.000536	0.00191	CcSEcCtD
Triamterene—Hypersensitivity—Thiotepa—breast cancer	0.000536	0.0019	CcSEcCtD
Triamterene—Dermatitis—Goserelin—breast cancer	0.000535	0.0019	CcSEcCtD
Triamterene—Headache—Goserelin—breast cancer	0.000532	0.00189	CcSEcCtD
Triamterene—Nausea—Tamoxifen—breast cancer	0.000528	0.00188	CcSEcCtD
Triamterene—Fatigue—Gemcitabine—breast cancer	0.000527	0.00187	CcSEcCtD
Triamterene—Dry mouth—Paclitaxel—breast cancer	0.000522	0.00186	CcSEcCtD
Triamterene—Asthenia—Thiotepa—breast cancer	0.000522	0.00185	CcSEcCtD
Triamterene—Diarrhoea—Vinorelbine—breast cancer	0.000521	0.00185	CcSEcCtD
Triamterene—Nausea—Melphalan—breast cancer	0.000517	0.00184	CcSEcCtD
Triamterene—Anaphylactic shock—Paclitaxel—breast cancer	0.000512	0.00182	CcSEcCtD
Triamterene—Nausea—Goserelin—breast cancer	0.000505	0.00179	CcSEcCtD
Triamterene—Dizziness—Vinorelbine—breast cancer	0.000503	0.00179	CcSEcCtD
Triamterene—Photosensitivity reaction—Methotrexate—breast cancer	0.000502	0.00178	CcSEcCtD
Triamterene—Hypokalaemia—Doxorubicin—breast cancer	0.000501	0.00178	CcSEcCtD
Triamterene—Thrombocytopenia—Paclitaxel—breast cancer	0.000501	0.00178	CcSEcCtD
Triamterene—Diarrhoea—Thiotepa—breast cancer	0.000497	0.00177	CcSEcCtD
Triamterene—Vomiting—Vinorelbine—breast cancer	0.000484	0.00172	CcSEcCtD
Triamterene—Dizziness—Thiotepa—breast cancer	0.000481	0.00171	CcSEcCtD
Triamterene—Rash—Vinorelbine—breast cancer	0.00048	0.00171	CcSEcCtD
Triamterene—Dermatitis—Vinorelbine—breast cancer	0.000479	0.0017	CcSEcCtD
Triamterene—Headache—Vinorelbine—breast cancer	0.000477	0.0017	CcSEcCtD
Triamterene—Photosensitivity reaction—Epirubicin—breast cancer	0.00047	0.00167	CcSEcCtD
Triamterene—Hypersensitivity—Irinotecan—breast cancer	0.000462	0.00164	CcSEcCtD
Triamterene—Hypersensitivity—Mitoxantrone—breast cancer	0.000462	0.00164	CcSEcCtD
Triamterene—Vomiting—Thiotepa—breast cancer	0.000462	0.00164	CcSEcCtD
Triamterene—Rash—Thiotepa—breast cancer	0.000458	0.00163	CcSEcCtD
Triamterene—Dermatitis—Thiotepa—breast cancer	0.000458	0.00163	CcSEcCtD
Triamterene—Headache—Thiotepa—breast cancer	0.000455	0.00162	CcSEcCtD
Triamterene—Nausea—Vinorelbine—breast cancer	0.000452	0.00161	CcSEcCtD
Triamterene—Asthenia—Irinotecan—breast cancer	0.00045	0.0016	CcSEcCtD
Triamterene—Asthenia—Mitoxantrone—breast cancer	0.00045	0.0016	CcSEcCtD
Triamterene—Jaundice—Epirubicin—breast cancer	0.000447	0.00159	CcSEcCtD
Triamterene—Hypersensitivity—Fluorouracil—breast cancer	0.000443	0.00157	CcSEcCtD
Triamterene—Dry mouth—Docetaxel—breast cancer	0.000443	0.00157	CcSEcCtD
Triamterene—Fatigue—Paclitaxel—breast cancer	0.000441	0.00157	CcSEcCtD
Triamterene—Asthenia—Gemcitabine—breast cancer	0.000439	0.00156	CcSEcCtD
Triamterene—Photosensitivity reaction—Doxorubicin—breast cancer	0.000435	0.00155	CcSEcCtD
Triamterene—Anaphylactic shock—Docetaxel—breast cancer	0.000434	0.00154	CcSEcCtD
Triamterene—Nausea—Thiotepa—breast cancer	0.000432	0.00154	CcSEcCtD
Triamterene—Diarrhoea—Irinotecan—breast cancer	0.000429	0.00153	CcSEcCtD
Triamterene—Diarrhoea—Mitoxantrone—breast cancer	0.000429	0.00153	CcSEcCtD
Triamterene—Dry mouth—Capecitabine—breast cancer	0.000429	0.00152	CcSEcCtD
Triamterene—Thrombocytopenia—Docetaxel—breast cancer	0.000425	0.00151	CcSEcCtD
Triamterene—Diarrhoea—Gemcitabine—breast cancer	0.000418	0.00149	CcSEcCtD
Triamterene—Dizziness—Irinotecan—breast cancer	0.000415	0.00148	CcSEcCtD
Triamterene—Jaundice—Doxorubicin—breast cancer	0.000414	0.00147	CcSEcCtD
Triamterene—Diarrhoea—Fluorouracil—breast cancer	0.000411	0.00146	CcSEcCtD
Triamterene—Thrombocytopenia—Capecitabine—breast cancer	0.000411	0.00146	CcSEcCtD
Triamterene—Vomiting—Mitoxantrone—breast cancer	0.000399	0.00142	CcSEcCtD
Triamterene—Vomiting—Irinotecan—breast cancer	0.000399	0.00142	CcSEcCtD
Triamterene—Dizziness—Fluorouracil—breast cancer	0.000398	0.00141	CcSEcCtD
Triamterene—Rash—Irinotecan—breast cancer	0.000396	0.00141	CcSEcCtD
Triamterene—Rash—Mitoxantrone—breast cancer	0.000396	0.00141	CcSEcCtD
Triamterene—Dermatitis—Mitoxantrone—breast cancer	0.000395	0.00141	CcSEcCtD
Triamterene—Dermatitis—Irinotecan—breast cancer	0.000395	0.00141	CcSEcCtD
Triamterene—Headache—Mitoxantrone—breast cancer	0.000393	0.0014	CcSEcCtD
Triamterene—Headache—Irinotecan—breast cancer	0.000393	0.0014	CcSEcCtD
Triamterene—Vomiting—Gemcitabine—breast cancer	0.000389	0.00138	CcSEcCtD
Triamterene—Rash—Gemcitabine—breast cancer	0.000386	0.00137	CcSEcCtD
Triamterene—Dermatitis—Gemcitabine—breast cancer	0.000385	0.00137	CcSEcCtD
Triamterene—Headache—Gemcitabine—breast cancer	0.000383	0.00136	CcSEcCtD
Triamterene—Vomiting—Fluorouracil—breast cancer	0.000382	0.00136	CcSEcCtD
Triamterene—Rash—Fluorouracil—breast cancer	0.000379	0.00135	CcSEcCtD
Triamterene—Dermatitis—Fluorouracil—breast cancer	0.000379	0.00135	CcSEcCtD
Triamterene—Hypersensitivity—Paclitaxel—breast cancer	0.000377	0.00134	CcSEcCtD
Triamterene—Headache—Fluorouracil—breast cancer	0.000377	0.00134	CcSEcCtD
Triamterene—Fatigue—Docetaxel—breast cancer	0.000374	0.00133	CcSEcCtD
Triamterene—Nausea—Irinotecan—breast cancer	0.000373	0.00133	CcSEcCtD
Triamterene—Nausea—Mitoxantrone—breast cancer	0.000373	0.00133	CcSEcCtD
Triamterene—Asthenia—Paclitaxel—breast cancer	0.000367	0.00131	CcSEcCtD
Triamterene—Nausea—Gemcitabine—breast cancer	0.000363	0.00129	CcSEcCtD
Triamterene—Fatigue—Capecitabine—breast cancer	0.000362	0.00129	CcSEcCtD
Triamterene—Nausea—Fluorouracil—breast cancer	0.000357	0.00127	CcSEcCtD
Triamterene—Diarrhoea—Paclitaxel—breast cancer	0.00035	0.00125	CcSEcCtD
Triamterene—Dizziness—Paclitaxel—breast cancer	0.000339	0.0012	CcSEcCtD
Triamterene—Vomiting—Paclitaxel—breast cancer	0.000326	0.00116	CcSEcCtD
Triamterene—Rash—Paclitaxel—breast cancer	0.000323	0.00115	CcSEcCtD
Triamterene—Dermatitis—Paclitaxel—breast cancer	0.000322	0.00115	CcSEcCtD
Triamterene—Headache—Paclitaxel—breast cancer	0.000321	0.00114	CcSEcCtD
Triamterene—Hypersensitivity—Docetaxel—breast cancer	0.00032	0.00114	CcSEcCtD
Triamterene—Anaphylactic shock—Methotrexate—breast cancer	0.000313	0.00111	CcSEcCtD
Triamterene—Asthenia—Docetaxel—breast cancer	0.000311	0.00111	CcSEcCtD
Triamterene—Hypersensitivity—Capecitabine—breast cancer	0.00031	0.0011	CcSEcCtD
Triamterene—Thrombocytopenia—Methotrexate—breast cancer	0.000306	0.00109	CcSEcCtD
Triamterene—Nausea—Paclitaxel—breast cancer	0.000304	0.00108	CcSEcCtD
Triamterene—Asthenia—Capecitabine—breast cancer	0.000301	0.00107	CcSEcCtD
Triamterene—Dry mouth—Epirubicin—breast cancer	0.000299	0.00106	CcSEcCtD
Triamterene—Diarrhoea—Docetaxel—breast cancer	0.000297	0.00106	CcSEcCtD
Triamterene—Anaphylactic shock—Epirubicin—breast cancer	0.000293	0.00104	CcSEcCtD
Triamterene—Diarrhoea—Capecitabine—breast cancer	0.000287	0.00102	CcSEcCtD
Triamterene—Dizziness—Docetaxel—breast cancer	0.000287	0.00102	CcSEcCtD
Triamterene—Thrombocytopenia—Epirubicin—breast cancer	0.000287	0.00102	CcSEcCtD
Triamterene—Dizziness—Capecitabine—breast cancer	0.000278	0.000988	CcSEcCtD
Triamterene—Dry mouth—Doxorubicin—breast cancer	0.000276	0.000982	CcSEcCtD
Triamterene—Vomiting—Docetaxel—breast cancer	0.000276	0.000981	CcSEcCtD
Triamterene—Rash—Docetaxel—breast cancer	0.000274	0.000973	CcSEcCtD
Triamterene—Dermatitis—Docetaxel—breast cancer	0.000273	0.000972	CcSEcCtD
Triamterene—Headache—Docetaxel—breast cancer	0.000272	0.000967	CcSEcCtD
Triamterene—Anaphylactic shock—Doxorubicin—breast cancer	0.000271	0.000963	CcSEcCtD
Triamterene—Fatigue—Methotrexate—breast cancer	0.00027	0.000959	CcSEcCtD
Triamterene—Vomiting—Capecitabine—breast cancer	0.000267	0.00095	CcSEcCtD
Triamterene—Thrombocytopenia—Doxorubicin—breast cancer	0.000265	0.000943	CcSEcCtD
Triamterene—Rash—Capecitabine—breast cancer	0.000265	0.000942	CcSEcCtD
Triamterene—Dermatitis—Capecitabine—breast cancer	0.000265	0.000941	CcSEcCtD
Triamterene—Headache—Capecitabine—breast cancer	0.000263	0.000936	CcSEcCtD
Triamterene—Nausea—Docetaxel—breast cancer	0.000258	0.000916	CcSEcCtD
Triamterene—Fatigue—Epirubicin—breast cancer	0.000252	0.000897	CcSEcCtD
Triamterene—Nausea—Capecitabine—breast cancer	0.00025	0.000887	CcSEcCtD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ALB—breast cancer	0.00024	0.00152	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ALB—breast cancer	0.00024	0.00152	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ALB—breast cancer	0.00024	0.00152	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—breast cancer	0.000239	0.00152	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—breast cancer	0.000239	0.00151	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—breast cancer	0.000238	0.00151	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—breast cancer	0.000238	0.00151	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTA4—breast cancer	0.000236	0.0015	CbGpPWpGaD
Triamterene—Fatigue—Doxorubicin—breast cancer	0.000233	0.00083	CcSEcCtD
Triamterene—CYP1A2—Tryptophan metabolism—CYP3A4—breast cancer	0.000232	0.00147	CbGpPWpGaD
Triamterene—Hypersensitivity—Methotrexate—breast cancer	0.00023	0.000819	CcSEcCtD
Triamterene—CYP1A2—Phase II conjugation—GSTA2—breast cancer	0.00023	0.00146	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—breast cancer	0.000228	0.00144	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—CYP1B1—breast cancer	0.000228	0.00144	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—breast cancer	0.000228	0.00144	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—SULT1A1—breast cancer	0.000227	0.00144	CbGpPWpGaD
Triamterene—Asthenia—Methotrexate—breast cancer	0.000224	0.000798	CcSEcCtD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HSP90AA1—breast cancer	0.000224	0.00142	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—HSP90AA1—breast cancer	0.000224	0.00142	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTA1—breast cancer	0.000222	0.00141	CbGpPWpGaD
Triamterene—CYP1A2—Estrogen Receptor Pathway—STAT3—breast cancer	0.00022	0.0014	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—NAT2—breast cancer	0.00022	0.00139	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—breast cancer	0.000219	0.00139	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NCOA1—breast cancer	0.000218	0.00138	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—RAF1—breast cancer	0.000217	0.00137	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—RAF1—breast cancer	0.000217	0.00137	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—RAF1—breast cancer	0.000217	0.00137	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—RAF1—breast cancer	0.000217	0.00137	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—breast cancer	0.000216	0.00137	CbGpPWpGaD
Triamterene—Hypersensitivity—Epirubicin—breast cancer	0.000216	0.000767	CcSEcCtD
Triamterene—CYP1A2—Tryptophan metabolism—CYP19A1—breast cancer	0.000214	0.00136	CbGpPWpGaD
Triamterene—Diarrhoea—Methotrexate—breast cancer	0.000214	0.000761	CcSEcCtD
Triamterene—CYP1A2—Arachidonic acid metabolism—CYP1B1—breast cancer	0.000213	0.00135	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—breast cancer	0.000213	0.00135	CbGpPWpGaD
Triamterene—Asthenia—Epirubicin—breast cancer	0.00021	0.000747	CcSEcCtD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—breast cancer	0.00021	0.00133	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—NCOA2—breast cancer	0.000209	0.00132	CbGpPWpGaD
Triamterene—Dizziness—Methotrexate—breast cancer	0.000207	0.000735	CcSEcCtD
Triamterene—Diarrhoea—Epirubicin—breast cancer	0.0002	0.000712	CcSEcCtD
Triamterene—Hypersensitivity—Doxorubicin—breast cancer	0.0002	0.000709	CcSEcCtD
Triamterene—Vomiting—Methotrexate—breast cancer	0.000199	0.000707	CcSEcCtD
Triamterene—Rash—Methotrexate—breast cancer	0.000197	0.000701	CcSEcCtD
Triamterene—Dermatitis—Methotrexate—breast cancer	0.000197	0.0007	CcSEcCtD
Triamterene—Headache—Methotrexate—breast cancer	0.000196	0.000697	CcSEcCtD
Triamterene—Asthenia—Doxorubicin—breast cancer	0.000194	0.000691	CcSEcCtD
Triamterene—Dizziness—Epirubicin—breast cancer	0.000194	0.000688	CcSEcCtD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—breast cancer	0.000188	0.00119	CbGpPWpGaD
Triamterene—Vomiting—Epirubicin—breast cancer	0.000186	0.000662	CcSEcCtD
Triamterene—Nausea—Methotrexate—breast cancer	0.000186	0.000661	CcSEcCtD
Triamterene—Diarrhoea—Doxorubicin—breast cancer	0.000185	0.000659	CcSEcCtD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—breast cancer	0.000185	0.00117	CbGpPWpGaD
Triamterene—Rash—Epirubicin—breast cancer	0.000185	0.000656	CcSEcCtD
Triamterene—Dermatitis—Epirubicin—breast cancer	0.000184	0.000656	CcSEcCtD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—breast cancer	0.000184	0.00117	CbGpPWpGaD
Triamterene—Headache—Epirubicin—breast cancer	0.000183	0.000652	CcSEcCtD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—breast cancer	0.000183	0.00116	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—breast cancer	0.000182	0.00115	CbGpPWpGaD
Triamterene—Dizziness—Doxorubicin—breast cancer	0.000179	0.000637	CcSEcCtD
Triamterene—CYP1A2—Phase II conjugation—MTR—breast cancer	0.000179	0.00113	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—breast cancer	0.000178	0.00113	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—breast cancer	0.000178	0.00113	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—breast cancer	0.000176	0.00112	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—NCOA1—breast cancer	0.000176	0.00111	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—breast cancer	0.000176	0.00111	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—HPGDS—breast cancer	0.000176	0.00111	CbGpPWpGaD
Triamterene—Nausea—Epirubicin—breast cancer	0.000174	0.000618	CcSEcCtD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—breast cancer	0.000173	0.0011	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—breast cancer	0.000173	0.00109	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—CYP1A1—breast cancer	0.000173	0.00109	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—breast cancer	0.000173	0.00109	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—breast cancer	0.000172	0.00109	CbGpPWpGaD
Triamterene—Vomiting—Doxorubicin—breast cancer	0.000172	0.000612	CcSEcCtD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—breast cancer	0.000171	0.00108	CbGpPWpGaD
Triamterene—Rash—Doxorubicin—breast cancer	0.000171	0.000607	CcSEcCtD
Triamterene—Dermatitis—Doxorubicin—breast cancer	0.000171	0.000607	CcSEcCtD
Triamterene—CYP1A2—Arachidonic acid metabolism—PLA2G4A—breast cancer	0.000171	0.00108	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTT1—breast cancer	0.00017	0.00108	CbGpPWpGaD
Triamterene—Headache—Doxorubicin—breast cancer	0.00017	0.000603	CcSEcCtD
Triamterene—CYP1A2—Biological oxidations—ALDH1A1—breast cancer	0.00017	0.00107	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—NCOA2—breast cancer	0.000169	0.00107	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—GPX1—breast cancer	0.000163	0.00103	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—CYP1A1—breast cancer	0.000162	0.00102	CbGpPWpGaD
Triamterene—Nausea—Doxorubicin—breast cancer	0.000161	0.000572	CcSEcCtD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—breast cancer	0.000152	0.000964	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—breast cancer	0.000152	0.000963	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTA3—breast cancer	0.000151	0.000958	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—breast cancer	0.000149	0.000947	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTA3—breast cancer	0.000149	0.000944	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—breast cancer	0.000143	0.000907	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—NCOA1—breast cancer	0.000143	0.000903	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—breast cancer	0.000141	0.00089	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—breast cancer	0.00014	0.000885	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTA4—breast cancer	0.000138	0.000876	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—breast cancer	0.000138	0.000874	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTA4—breast cancer	0.000136	0.000864	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTA2—breast cancer	0.000135	0.000854	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—SULT1A1—breast cancer	0.000133	0.000843	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GPX2—breast cancer	0.000133	0.000842	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GPX4—breast cancer	0.000131	0.000831	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—SULT1A1—breast cancer	0.000131	0.000831	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTA1—breast cancer	0.00013	0.000823	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—NAT2—breast cancer	0.000129	0.000814	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—NAT2—breast cancer	0.000127	0.000803	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—RB1—breast cancer	0.000125	0.000792	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—COMT—breast cancer	0.000119	0.000752	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTP1—breast cancer	0.000118	0.000748	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	0.000113	0.000718	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—SYNJ2—breast cancer	0.000109	0.000689	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTM1—breast cancer	0.000108	0.000687	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—breast cancer	0.000107	0.000679	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—MDM2—breast cancer	0.000107	0.000675	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—breast cancer	0.000106	0.000673	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—RELA—breast cancer	0.000106	0.00067	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—MTR—breast cancer	0.000105	0.000664	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—breast cancer	0.000103	0.000651	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—HPGDS—breast cancer	0.000103	0.000651	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTT1—breast cancer	9.96e-05	0.000631	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—breast cancer	9.73e-05	0.000617	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—breast cancer	9.73e-05	0.000617	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—PTGS2—breast cancer	9.61e-05	0.000609	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—breast cancer	9.56e-05	0.000606	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—breast cancer	9.53e-05	0.000604	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP17A1—breast cancer	9.43e-05	0.000598	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—PTGS1—breast cancer	9.34e-05	0.000592	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP17A1—breast cancer	9.3e-05	0.000589	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—breast cancer	9.27e-05	0.000587	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP2D6—breast cancer	9.16e-05	0.00058	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP2D6—breast cancer	9.03e-05	0.000572	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—NCOA2—breast cancer	8.99e-05	0.000569	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—breast cancer	8.98e-05	0.000569	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—SRC—breast cancer	8.31e-05	0.000527	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—breast cancer	8.31e-05	0.000527	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—breast cancer	8.09e-05	0.000513	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP3A4—breast cancer	8.08e-05	0.000512	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP3A4—breast cancer	7.96e-05	0.000505	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP1B1—breast cancer	7.94e-05	0.000503	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	7.93e-05	0.000502	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP1B1—breast cancer	7.83e-05	0.000496	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—NCOA1—breast cancer	7.57e-05	0.00048	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP19A1—breast cancer	7.46e-05	0.000473	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—MYC—breast cancer	7.45e-05	0.000472	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—breast cancer	7.43e-05	0.000471	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP19A1—breast cancer	7.36e-05	0.000466	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—breast cancer	7.28e-05	0.000462	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—breast cancer	7.28e-05	0.000462	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	7.2e-05	0.000456	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	7.2e-05	0.000456	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—COMT—breast cancer	6.94e-05	0.00044	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—breast cancer	6.94e-05	0.00044	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—breast cancer	6.94e-05	0.00044	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTP1—breast cancer	6.91e-05	0.000438	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—breast cancer	6.88e-05	0.000436	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—COMT—breast cancer	6.84e-05	0.000434	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—HADHB—breast cancer	6.83e-05	0.000432	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTP1—breast cancer	6.81e-05	0.000432	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTM1—breast cancer	6.35e-05	0.000402	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTM1—breast cancer	6.26e-05	0.000397	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—FHL2—breast cancer	6.24e-05	0.000396	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP1A1—breast cancer	6.02e-05	0.000381	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP1A1—breast cancer	5.93e-05	0.000376	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—breast cancer	5.85e-05	0.000371	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	5.8e-05	0.000368	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	5.62e-05	0.000356	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—GPX2—breast cancer	5.17e-05	0.000328	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—breast cancer	5.11e-05	0.000324	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—breast cancer	4.99e-05	0.000316	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SYNJ2—breast cancer	4.84e-05	0.000307	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NDUFS3—breast cancer	4.5e-05	0.000285	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—MED12—breast cancer	4.33e-05	0.000274	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CHST9—breast cancer	4.23e-05	0.000268	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	4.14e-05	0.000262	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	4.02e-05	0.000255	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—COX11—breast cancer	4.01e-05	0.000254	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	3.94e-05	0.00025	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—breast cancer	3.83e-05	0.000242	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CDA—breast cancer	3.67e-05	0.000232	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SHMT1—breast cancer	3.67e-05	0.000232	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	3.62e-05	0.000229	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	3.59e-05	0.000227	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLCO1B1—breast cancer	3.53e-05	0.000224	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC2A5—breast cancer	3.53e-05	0.000224	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	3.45e-05	0.000219	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APRT—breast cancer	3.41e-05	0.000216	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—FASN—breast cancer	3.35e-05	0.000212	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—breast cancer	3.33e-05	0.000211	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ANGPTL4—breast cancer	3.21e-05	0.000203	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ESRRA—breast cancer	3.21e-05	0.000203	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	3.05e-05	0.000193	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GPI—breast cancer	3.04e-05	0.000193	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HADHB—breast cancer	3.04e-05	0.000193	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	2.91e-05	0.000184	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALDH7A1—breast cancer	2.9e-05	0.000184	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALDH1A1—breast cancer	2.9e-05	0.000184	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	2.87e-05	0.000182	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ADSL—breast cancer	2.78e-05	0.000176	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—UMPS—breast cancer	2.78e-05	0.000176	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PHGDH—breast cancer	2.78e-05	0.000176	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—FHL2—breast cancer	2.78e-05	0.000176	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NME1—breast cancer	2.78e-05	0.000176	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LDHB—breast cancer	2.73e-05	0.000173	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HPSE—breast cancer	2.73e-05	0.000173	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—BRIP1—breast cancer	2.73e-05	0.000173	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ABCC1—breast cancer	2.58e-05	0.000164	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HMMR—breast cancer	2.58e-05	0.000164	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTA3—breast cancer	2.58e-05	0.000164	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PPARGC1B—breast cancer	2.5e-05	0.000159	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	2.44e-05	0.000154	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	2.44e-05	0.000154	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTA4—breast cancer	2.36e-05	0.00015	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CA9—breast cancer	2.36e-05	0.00015	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	2.33e-05	0.000148	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	2.31e-05	0.000146	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTA2—breast cancer	2.3e-05	0.000146	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GPX2—breast cancer	2.3e-05	0.000146	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GPX4—breast cancer	2.28e-05	0.000144	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SULT1A1—breast cancer	2.28e-05	0.000144	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTA1—breast cancer	2.22e-05	0.000141	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—IDH1—breast cancer	2.22e-05	0.000141	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NAT2—breast cancer	2.2e-05	0.000139	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.99e-05	0.000126	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—DPYD—breast cancer	1.93e-05	0.000122	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MED12—breast cancer	1.93e-05	0.000122	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALDOA—breast cancer	1.9e-05	0.00012	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NCOA3—breast cancer	1.84e-05	0.000117	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC2A2—breast cancer	1.83e-05	0.000116	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.81e-05	0.000115	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ABCG2—breast cancer	1.79e-05	0.000114	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CPT1A—breast cancer	1.79e-05	0.000114	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MTR—breast cancer	1.79e-05	0.000114	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HPGDS—breast cancer	1.76e-05	0.000111	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HBA1—breast cancer	1.75e-05	0.000111	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ACHE—breast cancer	1.7e-05	0.000108	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTT1—breast cancer	1.7e-05	0.000108	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP17A1—breast cancer	1.61e-05	0.000102	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ENO1—breast cancer	1.6e-05	0.000101	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PTGS1—breast cancer	1.6e-05	0.000101	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.59e-05	0.000101	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.57e-05	9.95e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP2D6—breast cancer	1.57e-05	9.92e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NCOA2—breast cancer	1.54e-05	9.74e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—FASN—breast cancer	1.49e-05	9.45e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—BCHE—breast cancer	1.48e-05	9.41e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC5A5—breast cancer	1.47e-05	9.29e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC2A1—breast cancer	1.42e-05	8.97e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NQO1—breast cancer	1.42e-05	8.97e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.39e-05	8.79e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP3A4—breast cancer	1.38e-05	8.75e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.37e-05	8.71e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP1B1—breast cancer	1.36e-05	8.6e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HSP90AA1—breast cancer	1.33e-05	8.44e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NCOA1—breast cancer	1.3e-05	8.21e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—STK11—breast cancer	1.28e-05	8.09e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP19A1—breast cancer	1.28e-05	8.09e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.2e-05	7.59e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—COMT—breast cancer	1.19e-05	7.52e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTP1—breast cancer	1.18e-05	7.48e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HMOX1—breast cancer	1.16e-05	7.38e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ITPR1—breast cancer	1.16e-05	7.36e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ABCB1—breast cancer	1.12e-05	7.08e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—TYMS—breast cancer	1.1e-05	6.96e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.09e-05	6.88e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NCOR1—breast cancer	1.09e-05	6.88e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTM1—breast cancer	1.09e-05	6.88e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GPX1—breast cancer	1.04e-05	6.59e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP1A1—breast cancer	1.03e-05	6.52e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ERCC2—breast cancer	1.02e-05	6.47e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MTHFR—breast cancer	9.59e-06	6.08e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CAV1—breast cancer	8.85e-06	5.61e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.45e-06	5.36e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CG—breast cancer	8.06e-06	5.11e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CD—breast cancer	7.08e-06	4.49e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALB—breast cancer	6.99e-06	4.43e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NOS3—breast cancer	6.69e-06	4.24e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CB—breast cancer	6.18e-06	3.91e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PTGS2—breast cancer	6.12e-06	3.88e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PTEN—breast cancer	5.34e-06	3.38e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CA—breast cancer	3.76e-06	2.39e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AKT1—breast cancer	3.08e-06	1.95e-05	CbGpPWpGaD
